-
Published 4/29/2026
Malatesta S, Carney T, Niemand Wolhuter N, Overbeck V, Theron D, Weber SE, Meade CS, Thomson S, Bouton TC, Farhat M, Myers B, Wood R, Ratangee F, Horsburgh CR, White LF, Warren RM, Jacobson KR. Tuberculosis Disease Prevalence Among People Who Smoke Illicit Drugs: A Respondent- Driven Sampling Study in the Western Cape, South Africa. J Infect Dis. 2026 Apr 29; 233(4):763-772. PMID: 41060285.
-
Published 2/11/2026
Thomson S, Overbeck V, Theron D, Botha B, Malatesta S, Bouton TC, Niemand Wolhuter N, Ratangee F, Campbell JI, Cesare N, Kulkarni Goodwin S, Meade CS, Horsburgh CR, White LF, Myers B, Warren RM, Carney T, Jacobson KR. Linkage to TB and HIV care for persons who smoke illicit drugs: a prospective cohort study. IJTLD Open. 2026 Feb; 3(2):91-96. PMID: 41847680.
-
Published 1/30/2026
Tabackman A, Acuña-Villaorduña C, Canning M, Karoly M, Dauphinais MR, Michaud R, Bouton TC, Bourque DL, Reifler KA, Sabharwal V, Traber K, Gupte AN, Jacobson KR, Sinha P. Low TB1 and TB2 antigen-nil is associated with increased QuantiFERON Gold Plus reversions. Int J Tuberc Lung Dis. 2026 Jan 30; 30(2):88-89. PMID: 41618115.
-
Published 1/2/2026
Martins MF, Teran Plasencia JM, Jacobson KR, Bouton TC, Traber KE, Canning M, Bourque DL, Sabharwal V, Michaud R, Sinha P, Acuña-Villaorduña CJ. Shorter regimens for TB preventive treatment: implementation challenges and priorities. Int J Tuberc Lung Dis. 2026 Jan 02; 30(1):43-44. PMID: 41482619.
-
Published 8/29/2025
Niemand N, Rooney JA, Malatesta S, Rawoot N, Bouton TC, Ragan EJ, Carney T, White LF, Farhat M, Horsburgh CR, Myers B, Warren RM, Jacobson KR. Contamination rates in serially sampled sputum specimens obtained during tuberculosis treatment to capture culture conversion. Microbiol Spectr. 2025 Oct 07; 13(10):e0096925. PMID: 40879468.